Amarin (AMRN) News Today $9.81 +0.34 (+3.59%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$9.75 -0.06 (-0.62%) As of 04/15/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Amarin (NASDAQ:AMRN) Sets New 12-Month Low - What's Next?Amarin (NASDAQ:AMRN) Reaches New 12-Month Low - What's Next?April 13 at 9:41 AM | marketbeat.comAmarin (NASDAQ:AMRN) Sets New 52-Week Low - Here's What HappenedApril 13 at 2:28 AM | americanbankingnews.comAmarin trading halted, news pendingApril 11, 2025 | markets.businessinsider.comAmarin confirms effective data for 1-for-20 ADS ratio changeApril 9, 2025 | markets.businessinsider.comAmarin Confirms Effective Date for 1-For-20 ADS Ratio ChangeApril 9, 2025 | globenewswire.comAmarin Confirms Effective Date for 1-For-20 ADS Ratio ChangeApril 9, 2025 | globenewswire.comStockNews.com Begins Coverage on Amarin (NASDAQ:AMRN)StockNews.com began coverage on shares of Amarin in a report on Tuesday. They issued a "sell" rating on the stock.April 9, 2025 | marketbeat.comAmarin Appoints JEC Capital Partners’ Michael Torok to Board of DirectorsApril 7, 2025 | finance.yahoo.comAmarin Appoints JEC Capital Partners' Michael Torok to Board of DirectorsApril 7, 2025 | globenewswire.comAmarin presents data at ACC.25 on EPA in lipoprotein-enriched plasmaApril 1, 2025 | markets.businessinsider.comAmarin (NASDAQ:AMRN) Earns Sell Rating from Analysts at StockNews.comStockNews.com assumed coverage on shares of Amarin in a report on Monday. They issued a "sell" rating for the company.March 31, 2025 | marketbeat.comAmarin Co. plc (NASDAQ:AMRN) Short Interest Down 35.4% in MarchAmarin Co. plc (NASDAQ:AMRN - Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 10,840,000 shares, a decrease of 35.4% from the February 28th total of 16,790,000 shares. Currently, 2.7% of the shares of the stock are sold short. Based on an average daily volume of 1,580,000 shares, the short-interest ratio is currently 6.9 days.March 30, 2025 | marketbeat.comAmarin Stock Set to Reverse Split on Friday, April 11th (NASDAQ:AMRN)Shares of Amarin Co. plc (NASDAQ:AMRN - Free Report) are set to reverse split on Friday, April 11th. The 1-20 reverse split was announced on Wednesday, March 12th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, April 10th.March 26, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Coverage Initiated by Analysts at StockNews.comStockNews.com initiated coverage on Amarin in a report on Sunday. They issued a "sell" rating for the company.March 23, 2025 | marketbeat.comAmarin shareholder group urges board to initiate strategic reviewMarch 21, 2025 | markets.businessinsider.comAmarin announces additional in vitro data with EPA to be presentedMarch 20, 2025 | markets.businessinsider.comAmarin gains amid shareholder group push for strategic reviewMarch 19, 2025 | seekingalpha.comConcerned Shareholder Group Urges Amarin's Board of Directors to Initiate a Strategic Review Following Two Years of UnderperformanceMarch 19, 2025 | businesswire.comNew Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & ExpoMarch 19, 2025 | globenewswire.comAmarin (NASDAQ:AMRN) Cut to Sell at StockNews.comStockNews.com downgraded Amarin from a "hold" rating to a "sell" rating in a research note on Saturday.March 15, 2025 | marketbeat.comAmarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | msn.comAMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change PlanMarch 13, 2025 | msn.comAmarin (NASDAQ:AMRN) Releases Quarterly Earnings Results, Misses Expectations By $0.06 EPSAmarin (NASDAQ:AMRN - Get Free Report) released its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.06). Amarin had a negative return on equity of 7.22% and a negative net margin of 16.33%.March 13, 2025 | marketbeat.comAmarin Corporation’s Earnings Call: A Mixed OutlookMarch 12, 2025 | tipranks.comAmarin Plc (AMRN) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | finance.yahoo.comAmarin Corporation plc: Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) ProgramMarch 12, 2025 | finanznachrichten.deAmarin reports Q4 adjusted EPS (2c) vs. 0c last yearMarch 12, 2025 | markets.businessinsider.comAmarin announce splan to initiate ratio change under ADR programMarch 12, 2025 | markets.businessinsider.comAmarin drops despite Q4 beat amid ADS ratio changeMarch 12, 2025 | msn.comAmarin Corporation plc (AMRN) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comAmarin expects cash to support continuing operations for ‘foreseeable future’March 12, 2025 | markets.businessinsider.comAmarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) ProgramMarch 12, 2025 | markets.businessinsider.comAmarin (NASDAQ:AMRN) Stock Rating Upgraded by StockNews.comStockNews.com raised shares of Amarin from a "sell" rating to a "hold" rating in a research note on Friday.March 8, 2025 | marketbeat.comAmarin (AMRN) Expected to Announce Quarterly Earnings on WednesdayAmarin (NASDAQ:AMRN) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667912)March 5, 2025 | marketbeat.comAmarin’s vascepa shows cardiovascular efficacy in published trialFebruary 27, 2025 | markets.businessinsider.comAmarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol LoweringFebruary 27, 2025 | globenewswire.comAmarin (NASDAQ:AMRN) Stock Rating Lowered by StockNews.comStockNews.com downgraded shares of Amarin from a "hold" rating to a "sell" rating in a research note on Tuesday.February 26, 2025 | marketbeat.comAmarin receives national reimbursement for VAZKEPA in AustriaFebruary 26, 2025 | markets.businessinsider.comAmarin Receives National Reimbursement for VAZKEPA® in AustriaFebruary 25, 2025 | markets.businessinsider.comAmarin Co. plc (NASDAQ:AMRN) Shares Acquired by Waterfront Wealth Inc.Waterfront Wealth Inc. increased its position in shares of Amarin Co. plc (NASDAQ:AMRN - Free Report) by 181.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,481,766 shares of the biopharmaceutical company's stock after acquiriFebruary 22, 2025 | marketbeat.comAmarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025February 19, 2025 | globenewswire.comFY2025 Earnings Estimate for Amarin Issued By Zacks ResearchAmarin Co. plc (NASDAQ:AMRN - Free Report) - Equities researchers at Zacks Research reduced their FY2025 earnings per share estimates for Amarin in a research note issued on Tuesday, February 11th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will post earFebruary 15, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Raised to "Hold" at StockNews.comStockNews.com raised Amarin from a "sell" rating to a "hold" rating in a research note on Tuesday.February 11, 2025 | marketbeat.comLongitude Cayman Ltd. Sells 750,000 Shares of Amarin Co. plc (NASDAQ:AMRN)Longitude Cayman Ltd. cut its holdings in shares of Amarin Co. plc (NASDAQ:AMRN - Free Report) by 31.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,620,000 shares of the biopharmaceFebruary 11, 2025 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for WeekJanuary 24, 2025 | msn.comAmarin (NASDAQ:AMRN) Upgraded to Hold at StockNews.comStockNews.com raised shares of Amarin from a "sell" rating to a "hold" rating in a research report on Monday.January 13, 2025 | marketbeat.comFY2024 Earnings Estimate for Amarin Issued By Zacks ResearchAmarin Co. plc (NASDAQ:AMRN - Free Report) - Stock analysts at Zacks Research reduced their FY2024 EPS estimates for shares of Amarin in a research note issued to investors on Wednesday, January 8th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will post eJanuary 13, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Coverage Initiated at StockNews.comStockNews.com initiated coverage on Amarin in a research report on Sunday. They set a "sell" rating for the company.January 5, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Now Covered by StockNews.comStockNews.com initiated coverage on Amarin in a report on Friday. They set a "hold" rating on the stock.December 20, 2024 | marketbeat.comAmarin Receives National Reimbursement for VAZKEPA® in ItalyDecember 16, 2024 | globenewswire.com Remove Ads Get Amarin News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address AMRN Media Mentions By Week AMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRN News Sentiment▼0.240.78▲Average Medical News Sentiment AMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRN Articles This Week▼92▲AMRN Articles Average Week Remove Ads Get Amarin News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intellia Therapeutics News Zymeworks News Vir Biotechnology News Nurix Therapeutics News Anavex Life Sciences News Oculis News Avadel Pharmaceuticals News CureVac News Day One Biopharmaceuticals News AbCellera Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRN) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amarin Co. plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Amarin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMRN Stock Free AMRN Stock Alerts